R
Rafael Perera
Researcher at University of Oxford
Publications - 328
Citations - 31421
Rafael Perera is an academic researcher from University of Oxford. The author has contributed to research in topics: Randomized controlled trial & Systematic review. The author has an hindex of 65, co-authored 304 publications receiving 24264 citations. Previous affiliations of Rafael Perera include University of Southampton & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
Tammy Hoffmann,Paul Glasziou,Isabelle Boutron,Ruairidh Milne,Rafael Perera,David Moher,Douglas G. Altman,Virginia Barbour,Helen Macdonald,Marie Johnston,Sarah E Lamb,Mary Dixon-Woods,Peter McCulloch,Jeremy C Wyatt,An-Wen Chan,Susan Michie +15 more
TL;DR: The TIDieR checklist and guide should improve the reporting of interventions and make it easier for authors to structure accounts of their interventions, reviewers and editors to assess the descriptions, and readers to use the information.
Journal ArticleDOI
Factors associated with COVID-19-related death using OpenSAFELY.
Elizabeth A. Williamson,Alex J Walker,Krishnan Bhaskaran,Seb Bacon,Chris Bates,Caroline E Morton,Helen J Curtis,Amir Mehrkar,David M. Evans,Peter Inglesby,Jonathan Cockburn,Helen Mcdonald,Brian MacKenna,Laurie A. Tomlinson,Ian J. Douglas,Christopher T Rentsch,Rohini Mathur,Angel Y S Wong,Richard Grieve,David G. Harrison,Harriet Forbes,Anna Schultze,Richard Croker,John Parry,Frank Hester,Sam Harper,Rafael Perera,Stephen J. W. Evans,Liam Smeeth,Ben Goldacre +29 more
TL;DR: A range of clinical factors associated with COVID-19-related death is quantified in one of the largest cohort studies on this topic so far and includes people of white ethnicity, Black and South Asian people were at higher risk, even after adjustment for other factors.
Journal ArticleDOI
Nicotine replacement therapy for smoking cessation.
Lindsay F Stead,Rafael Perera,Chris Bullen,David Mant,Jamie Hartmann-Boyce,Kate Cahill,Tim Lancaster +6 more
TL;DR: In this article, the effectiveness of different forms of nicotine replacement therapy (chewing gum, transdermal patches, nasal spray, inhalers and tablets) in achieving abstinence from cigarettes, or a sustained reduction in amount smoked; to determine whether the effect is influenced by the clinical setting in which the smoker is recruited and treated, the dosage and form of the NRT used, or the intensity of additional advice and support offered to the smoker.
Journal Article
Better reporting of interventions: Template for intervention description and replication (TIDieR) checklist and guide
Tammy Hoffmann,Paul Glasziou,Isabelle Boutron,Ruairidh Milne,Rafael Perera,David Moher,Douglas G. Altman,Virginia Barbour,Helen Macdonald,Marie Johnston,Sarah E Lamb,Mary Dixon-Woods,Peter McCulloch,Jeremy C Wyatt,An-Wen Chan,Susan Michie +15 more
TL;DR: The TIDieR checklist and guide as mentioned in this paper is an extension of the CONSORT 2010 statement (item 5) and the SPIRIT 2013 statement, and is intended to improve the reporting of interventions and make it easier for authors to structure accounts of their interventions.
Journal ArticleDOI
Pharmacological interventions for smoking cessation: an overview and network meta‐analysis
TL;DR: The outcome for benefit is continuous or prolonged abstinence at least six months from the start of treatment, and the outcome for harms is the incidence of serious adverse events associated with each of the treatments.